Just diagnosed with Hemiparkinsonism-hemiatrophy syndrome?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Hemiparkinsonism-hemiatrophy syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Hemiparkinsonism-hemiatrophy syndrome hub →Overview
Hemiparkinsonism-hemiatrophy syndrome is a rare condition. Also known as HP-HA syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Hemiparkinsonism-hemiatrophy syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:306669 · ICD-10 G20 · GARD 0021262
Find care for Hemiparkinsonism-hemiatrophy syndrome
Authoritative references for Hemiparkinsonism-hemiatrophy syndrome
Research & market landscape for Hemiparkinsonism-hemiatrophy syndrome
Following Hemiparkinsonism-hemiatrophy syndrome for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Hemiparkinsonism-hemiatrophy syndrome — the real-world landscape behind the condition, in one place.
- Latest Hemiparkinsonism-hemiatrophy syndrome research on PubMed ↗
- Recruiting Hemiparkinsonism-hemiatrophy syndrome trials on ClinicalTrials.gov ↗
- Explore the Hemiparkinsonism-hemiatrophy syndrome research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Hemiparkinsonism-hemiatrophy syndrome and every rare condition. See how Tomeko works with industry →
Common questions
What is Hemiparkinsonism-hemiatrophy syndrome?
Hemiparkinsonism-hemiatrophy syndrome is a rare condition. Also known as HP-HA syndrome. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Hemiparkinsonism-hemiatrophy syndrome together in one place.
What are the symptoms of Hemiparkinsonism-hemiatrophy syndrome?
Symptoms of Hemiparkinsonism-hemiatrophy syndrome vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Hemiparkinsonism-hemiatrophy syndrome.
How is Hemiparkinsonism-hemiatrophy syndrome treated?
Treatment for Hemiparkinsonism-hemiatrophy syndrome depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Hemiparkinsonism-hemiatrophy syndrome, and review current options with them.
What causes Hemiparkinsonism-hemiatrophy syndrome — is it genetic?
The cause and inheritance of Hemiparkinsonism-hemiatrophy syndrome are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Hemiparkinsonism-hemiatrophy syndrome can explain what it means for you and your family.
I was just diagnosed with Hemiparkinsonism-hemiatrophy syndrome — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Hemiparkinsonism-hemiatrophy syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Hemiparkinsonism-hemiatrophy syndrome?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Hemiparkinsonism-hemiatrophy syndrome, filtered to your area.
Are there clinical trials for Hemiparkinsonism-hemiatrophy syndrome?
Tomeko shows live, recruiting studies for Hemiparkinsonism-hemiatrophy syndrome from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion